Clinical Trial Update: Clinical Investigation of the AcrySof® IQ PanOptix™ IOL [NA]

View source ↗

Summary

Clinical trial update for the AcrySof IQ PanOptix intraocular lens (IOL) investigated for cataract conditions; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Drugs mentioned

• AcrySof IQ PanOptix IOL (AcrySof IQ PanOptix IOL)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | NA | Status: COMPLETED | Results posted: 2019-09-24